Delivery Order SPE2DB22D1017-SPE2DB25FG4VW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60 count) with a ceiling value of $13,456.36. This is a firm fixed price delivery order with no set-aside designation, completed competitively, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of September 10, 2025. The award represents a single delivery order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count units) valued at $1,488.86. This firm fixed-price delivery order is expected to reach completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the vendor's capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $1,961.10 to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 250 mg tablets (120-count) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Abiraterone Acetate 250 mg tablets in a quantity of 120 units, with a ceiling value of $6,437.79. This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count) with a ceiling value of $8,006.80. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement needs across military...
- The Defense Logistics Agency awarded a $4,239.73 delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count package). This contract is a firm fixed price delivery order with an ultimate completion date of June 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $20,776.45 on June 11, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count). This is a firm fixed price, non-competitive delivery order with an ultimate completion date of June 12, 2025, to be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count) with a ceiling value of $21,098.76. This firm fixed-price delivery order, which has an ultimate completion date of June 3, 2025, carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a competitively awarded contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,745.56 delivery order to AmerisourceBergen Drug Corp for Abiraterone Acetate 250 mg tablets (120-count supply) under a firm fixed price contract. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025. This non-set-aside order represents a competitive award to support federal medical procurement needs, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 500 mg tablets (60-count) valued at $3,930.29. The contract is firm fixed price with no set-aside designation, competitively awarded, and scheduled for completion by September 26, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG4VWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,398.61 to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 500 mg tablets (60-count units) on June 12, 2025, with completion scheduled for June 13, 2025. The contract utilizes firm fixed price terms and is not designated as a set-aside award, indicating it was competitively awarded. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion master agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, with extensive experience fulfilling federal healthcare requirements through the DLA Medical Supply Chain. The company's contract portfolio demonstrates substantial capability in delivering diverse therapeutic medications, including specialty drugs, brand-name and generic pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Abiraterone Acetate—a prostate cancer treatment—exemplifies the company's role in ensuring pharmaceutical availability for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 6/12/25 |